Streptococcus pyogenes bacteraemia, emm types and superantigen profiles

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 5, 2012, Pages 859-865

  Rantala, S ^a   Vahakuopus S ^b   Siljander, T ^b   Vuopio, J ^b   Huhtala, H ^c   Vuento, R ^a   Syrjanen J ^a,d  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF TAMPERE   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

SUPERANTIGEN;

ABSCESS; ADULT; ARTICLE; BACTEREMIA; BACTERIAL GENE; BACTERIUM ISOLATION; EMM TYPING; FEMALE; FINLAND; GENOTYPE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; NONHUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; SEASONAL VARIATION; SKIN INFECTION; SOFT TISSUE INFECTION; SPEA GENE; SPEC GENE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PYOGENES; SUPERANTIGEN GENE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, BACTERIAL; BACTEREMIA; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; FEMALE; FINLAND; HUMANS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PREVALENCE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS PYOGENES; SUPERANTIGENS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84862858807     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1385-9     Document Type: Article

References (36)

1. Stevens DL (1992) Invasive group A Streptococcus infections. Clin Infect Dis 14: 2-11
2. Factor SH, Levine OS, Schwartz B, Harrison LH, Farley MM, McGeer A, Schuchat A (2003) Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis 9: 970-977
3. Davies HD, McGeer A, Schwartz B, Green K, Cann D, Simor AE, Low DE (1996) Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. NEngl J Med 335: 547-554
4. O'Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A, Albanese BA, Farley MM, Barrett NL, Spina NL, Beall B, Harrison LH, Reingold A, Van Beneden C, Active Bacterial Core Surveillance Team (2007) The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis 45: 853-862
5. O'Brien KL, Beall B, Barrett NL, Cieslak PR, Reingold A, Farley MM, Danila R, Zell ER, Facklam R, Schwartz B, Schuchat A (2002) Epidemiology of invasive group A Streptococcus isease in the United States, 1995-1999. Clin Infect Dis 35: 268-276
6. Eriksson BK, Norgren M, McGregor K, Spratt BG, Normark BH (2003) Group A streptococcal infections in Sweden: a comparative study of invasive and noninvasive infections and analysis of dominant T28 emm28 isolates. Clin Infect Dis 37: 1189-1193
7. Ekelund K, Darenberg J, Norrby-Teglund A, Hoffmann S, Bang D, Skinhøj P, Konradsen HB (2005) Variations in emm type among group A streptococcal isolates causing invasive or oninvasive infections in a nationwide study. J Clin Microbiol 43: 3101-3109
8. Darenberg J, Luca-Harari B, Jasir A, Sandgren A, Pettersson H, Schalén C, Norgren M, Romanus V, Norrby-Teglund A, Normark BH (2007) Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin Infect Dis 45: 450-458
9. Dale JB, Penfound T, Chiang EY, Long V, Shulman ST, Beall B (2005) Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes. Clin Diagn Lab Immunol 12: 833-836
10. McNeil SA, Halperin SA, Langley JM, Smith B, Warren A, Sharratt GP, Baxendale DM, Reddish MA, Hu MC, Stroop SD, Linden J, Fries LF, Vink PE, Dale JB (2005) Safety and immunogenicity of 26-valent group A Streptococcus vaccine in healthy adult volunteers. Clin Infect Dis 41: 1114-1122
11. Ikebe T, Hirasawa K, Suzuki R, Ohya H, Isobe J, Tanaka D, Katsukawa C, Kawahara R, Tomita M, Ogata K, Endoh M, Okuno R, Tada Y, Okabe N, Watanabe H, Working Group for etahaemolytic Streptococci in Japan (2007) Distribution of emm genotypes among group A Streptococcus isolates from patients with severe invasive streptococcal infections in Japan, 2001- 2005. Epidemiol Infect 135: 1227-1229
12. Steer AC, Law I, Matatolu L, Beall BW, Carapetis JR (2009) Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis 9: 611-616
13. Norrby-Teglund A, Kotb M (2000) Host-microbe interactions in the pathogenesis of invasive group A streptococcal infections. J Med Microbiol 49: 849-852
14. Lintges M, van der Linden M, Hilgers RD, Arlt S, Al-Lahham A, Reinert RR, Plücken S, Rink L (2010) Superantigen genes are more important than the emm type for the invasiveness of group A Streptococcus infection. J Infect Dis 202: 20-28
15. Kotb M (1995) Bacterial pyrogenic exotoxins as superantigens. Clin Microbiol Rev 8: 411-426
16. Rantala S, Vuopio-Varkila J, Vuento R, Huhtala H, Syrjänen J (2009) Clinical presentations and epidemiology of betahaemolytic streptococcal bacteraemia: a population-based study. Clin Microbiol Infect 15: 286-288
17. Rantala S, Vuopio-Varkila J, Vuento R, Huhtala H, Syrjänen J (2009) Predictors of mortality in beta-hemolytic streptococcal bacteremia: a population-based study. J Infect 58: 266-272
18. Schmitz FJ, Beyer A, Charpentier E, Normark BH, Schade M, Fluit AC, Hafner D, Novak R (2003) Toxin-gene profile heterogeneity among endemic invasive European group A streptococcal isolates. J Infect Dis 188: 1578-1586
19. Siljander T, Lyytikäinen O, Vähäkuopus S, Snellman M, Jalava J, Vuopio J (2010) Epidemiology, outcome and emm types of invasive group A streptococcal infections in Finland. Eur J Clin Microbiol 29: 1229-1235
20. Siljander T, Lyytikäinen O, Vähäkuopus S, Säilä P, Jalava J, Vuopio-Varkila J (2009) Rapid emergence of emm84 among invasive Streptococcus pyogenes infections in Finland. J Clin Microbiol 47: 477-480
21. Luca-Harari B, Ekelund K, van der Linden M, Staum-Kaltoft M, Hammerum AM, Jasir A (2008) Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004. J Clin Microbiol 46: 79-86
22. Lamagni TL, Neal S, Keshishian C, Hope V, George R, Duckworth G, Vuopio-Varkila J, Efstratiou A (2008) Epidemic of severe Streptococcus pyogenes infections in injecting drug users in the UK, 2003-2004. Clin Microbiol Infect 14: 1002-1009
23. Lamagni TL, Darenberg J, Luca-Harari B, Siljander T, Efstratiou A, Henriques-Normark B, Vuopio-Varkila J, Bouvet A, Creti R, Ekelund K, Koliou M, Reinert RR, Stathi A, Strakova L, Ungureanu V, Schalén C, Jasir A, Strep-EURO Study Group (2008) Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 46: 2359-2367
24. Factor SH, Levine OS, Harrison LH, Farley MM, McGeer A, Skoff T, Wright C, Schwartz B, Schuchat A (2005) Risk factors for pediatric invasive group A streptococcal disease. Emerg Infect Dis 11: 1062-1066
25. Spindler C, Hedlund J, Jasir A, Normark BH, Ortqvist A (2008) Effects of a large-scale introduction of the pneumococcal polysaccharide vaccine among elderly persons in Stockholm, Sweden. Vaccine 26: 5541-5546
26. Aguiar SI, Serrano I, Pinto FR, Melo-Cristino J, Ramirez M, Portuguese Surveillance Group for the Study of Respiratory Pathogens (2008) Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine. Clin Microbiol Infect 14: 835-843
27. Cunningham MW (2000) Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13: 470-511
28. Chatellier S, Ihendyane N, Kansal RG, Khambaty F, Basma H, Norrby-Teglund A, Low DE, McGeer A, Kotb M (2000) Genetic relatedness and superantigen expression in group A Streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun 68: 3523-3534
29. Bisno AL, Brito MO, Collins CM (2003) Molecular basis of group A streptococcal virulence. Lancet Infect Dis 3: 191-200
30. Talkington DF, Schwartz B, Black CM, Todd JK, Elliott J, Breiman RF, Facklam RR (1993) Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun 61: 3369-3374
31. Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM, Schlievert PM, Kaplan E (1989) Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 321: 1-7
32. Musser JM, Hauser AR, Kim MH, Schlievert PM, Nelson K, Selander RK (1991) Streptococcus pyogenes causing toxic-shocklike syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci USA 88: 2668-2672
33. Eriksson BK, Andersson J, Holm SE, Norgren M (1999) Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective ack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome. J Infect Dis 180: 410-418
34. Holm SE, Norrby A, Bergholm AM, Norgren M (1992) Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. J Infect Dis 166: 31-37
35. Demers B, Simor AE, Vellend H, Schlievert PM, Byrne S, Jamieson F, Walmsley S, Low DE (1993) Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin Infect Dis 16: 792-800
36. Hsueh PR, Wu JJ, Tsai PJ, Liu JW, Chuang YC, Luh KT (1998) Invasive group A streptococcal disease in Taiwan is not associated with the presence of streptococcal pyrogenic exotoxin genes. Clin Infect Dis 26: 584-589